Program Documentation. Provide program documentation, including:
Program Documentation. The Supplier shall, within 120 calendar days of submitting the final paperwork for a particular customer application under a Program, attend to destruction of the Supplier’s copy of the completed Program form(s) by shredding or other secure method and be prepared to certify same in writing to EM upon EM’s request.
Program Documentation. The “MISMO Software Compliance Certification Program Documentation” comprised of multiple documents as amended from time to time by the MISMO in its sole discretion, currently available at xxxxx.xxx.
Program Documentation. The MISMO Software Compliance Certification Overview and other supporting documentation for the MISMO Software Compliance Certification Program, as modified by MISMO from time to time in its sole discretion, and set forth at xxxx://xxxxx.xxx or such additional or replacement locations as provided by MISMO.
Program Documentation. The Licensee shall be provided "Documentation" describing in reasonable detail, understandable by a user of general proficiency, the use and operation of the Licensed Products. The Documentation shall be supplied in electronic form in the Licensed Product’s own internal help system, and on the Evisions’ website, and may be reproduced by Licensee solely in furtherance of its Use.
Program Documentation. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Program Documentation. Source Area Additional Information Suggested Mode of Transfer- Electronic or Paper Completion Date [*] [*] [*] [*] [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. SCHEDULE 1.41 PROGRAM DOCUMENTATION Source Area Scynexis Questions/Comments Merck Response [*] [*] [*] [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. SCHEDULE 1.45 Scynexis Letter to be Submitted to FDA May 28, 2013 Xxxx Xxxxxx, M.D., M.P.H., Acting Director Food and Drug Administration Center for Drug Evaluation and Research Division of Anti-Infective Products 0000-X Xxxxxxxxx Xxxx Xxxxxxxxxx, XX 00000-0000 Serial No. Dear Xx. Xxxxxx: IND 107,521: MK-3118 Transfer of Ownership of IND Reference is made to the subject Investigational New Drug (IND) application for MK-3118 for the treatment of fungal infections, which was submitted on January 12, 2010 (Serial No. 0000). Reference is also made to the letter dated [xx-xx-2013] from Merck Sharp & Dohme Corp. with regard to IND 107,521 (Serial # YYYY, see attached). This letter and the attached signed form FDA 1571 serve as confirmation of the acceptance by SCYNEXIS, Inc. of the transfer of ownership of the aforementioned IND from Merck Sharp & Dohme Corp, a subsidiary of Merck & Co, Inc. (Merck) to SCYNEXIS, Inc. The change in ownership becomes effective on 24-05-2013. The contact information for SCYNEXIS, Inc. is: Xxxxxx Xxxxxxx-Xxxxx Director, Clinical Affairs SCYNEXIS, Inc. 0000X Xxxxxxxxx Xxxxxxxxx Xxxxxx, XX 00000 Tel: 000-000-0000 Fax: 000-000-0000 Email: Xxxxxx.Xxxxxxx-Xxxxx@xxxxxxxx.xxx [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Pursuant to the provisions in 21 CFR 312, Section 312.50, all rights and responsibilities associated with the subject Investigational New Drug application are hereby accepted by SCYNEXIS, Inc. We consider the information included in this submission to be a confidential matter, and request that the Food and Drug Administration not make its content, public without first ...
Program Documentation. Required Re-SAP documents are shown in Attachment A-7.1. Attachment X-0 XXX 0000X XX-XXX LEASE PROGRAM General Description: -------------------- This program is offered for the purpose of re-SAPing returned QDR 4500C SAPs . Program prices are modified to reflect "used / demo" systems. Financial Arrangements: ----------------------- No new funding or revenue is available to PSS on these DXA leases. As an incentive to place Re-SAP units, a sales incentive equal to [Language Deleted Due To Confidential Treatment Request.] shall be paid to PSS. [Language Deleted Due To Confidential Treatment Request.] Customer financing allows normal SAP terms but modifies buyout price to [Language Deleted Due To Confidential Treatment Request.] and allows full credit of deposit to purchase (within first 12 months) and scans paid (within first 6 months) if converted to purchase. (see example contract)
Program Documentation. The Contractor shall submit quarterly reports to the Contract Administrator demonstrating compliance with the Department's Outreach Program, and make related records available to the Department upon request. The Reports shall be submitted on Department forms which can be obtained from the Contract Administrator, and show the following:
Program Documentation. Program user and installation manuals.
